

Core offering: Clinician-reviewed digital care platform providing personalized cannabinoid product, dose, and use guidance
Target users: Older adults and people in/after cancer treatment
Products: Hemp-derived, Farm Bill-compliant Delta-9 THC products (organic, 3rd-party tested, GMP)
Headquarters: Wellesley Hills, Massachusetts
Founders / leadership: Sean Collins (CEO, co-founder) and Dave Batista (CXO, co-founder)
Digital health; symptom management using clinician-guided cannabinoid therapies
Digital health / cannabinoid therapeutics
“Company lists committed investors and advisors including Regina Benjamin, Bill Van Faasen, and Kristi Savacool”